Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06554158Not ApplicableRecruiting

De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers

Role: collaborator

NCT05300685Phase 3Recruiting

Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty

Role: collaborator

NCT07131163Recruiting

Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection

Role: collaborator

NCT05925075Enrolling By Invitation

Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress

Role: collaborator

NCT04467931Completed

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Role: collaborator

NCT04226157Not ApplicableUnknown

Home Blood Pressure Study for Recent Stroke Survivors With High Blood Pressure *On Hold Due to Global Pandemic*

Role: lead

All 6 trials loaded